Millennium Veterinary Practice Limited 07378936 false 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is that of a veterinary practice. Digita Accounts Production Advanced 6.30.9574.0 true true 07378936 2023-10-01 2024-09-30 07378936 2024-09-30 07378936 bus:Director5 1 2024-09-30 07378936 core:AcceleratedTaxDepreciationDeferredTax 2024-09-30 07378936 core:CurrentFinancialInstruments 2024-09-30 07378936 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 07378936 core:Non-currentFinancialInstruments 2024-09-30 07378936 core:Non-currentFinancialInstruments core:AfterOneYear 2024-09-30 07378936 core:Goodwill 2024-09-30 07378936 core:ConstructionInProgressAssetsUnderConstruction 2024-09-30 07378936 core:FurnitureFittingsToolsEquipment 2024-09-30 07378936 core:MotorVehicles 2024-09-30 07378936 core:OtherPropertyPlantEquipment 2024-09-30 07378936 bus:SmallEntities 2023-10-01 2024-09-30 07378936 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 07378936 bus:FilletedAccounts 2023-10-01 2024-09-30 07378936 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 07378936 bus:RegisteredOffice 2023-10-01 2024-09-30 07378936 bus:Director4 2023-10-01 2024-09-30 07378936 bus:Director5 2023-10-01 2024-09-30 07378936 bus:Director5 1 2023-10-01 2024-09-30 07378936 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 07378936 core:Goodwill 2023-10-01 2024-09-30 07378936 core:ConstructionInProgressAssetsUnderConstruction 2023-10-01 2024-09-30 07378936 core:FurnitureFittings 2023-10-01 2024-09-30 07378936 core:FurnitureFittingsToolsEquipment 2023-10-01 2024-09-30 07378936 core:MotorVehicles 2023-10-01 2024-09-30 07378936 core:OfficeEquipment 2023-10-01 2024-09-30 07378936 core:OtherPropertyPlantEquipment 2023-10-01 2024-09-30 07378936 core:PlantMachinery 2023-10-01 2024-09-30 07378936 core:KeyManagementPersonnel 2023-10-01 2024-09-30 07378936 5 2023-10-01 2024-09-30 07378936 countries:EnglandWales 2023-10-01 2024-09-30 07378936 2023-09-30 07378936 bus:Director5 1 2023-09-30 07378936 core:Goodwill 2023-09-30 07378936 core:ConstructionInProgressAssetsUnderConstruction 2023-09-30 07378936 core:FurnitureFittingsToolsEquipment 2023-09-30 07378936 core:MotorVehicles 2023-09-30 07378936 core:OtherPropertyPlantEquipment 2023-09-30 07378936 2022-10-01 2023-09-30 07378936 2023-09-30 07378936 core:AcceleratedTaxDepreciationDeferredTax 2023-09-30 07378936 core:CurrentFinancialInstruments 2023-09-30 07378936 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 07378936 core:Non-currentFinancialInstruments 2023-09-30 07378936 core:Non-currentFinancialInstruments core:AfterOneYear 2023-09-30 07378936 core:Goodwill 2023-09-30 07378936 core:ConstructionInProgressAssetsUnderConstruction 2023-09-30 07378936 core:FurnitureFittingsToolsEquipment 2023-09-30 07378936 core:MotorVehicles 2023-09-30 07378936 core:OtherPropertyPlantEquipment 2023-09-30 iso4217:GBP xbrli:pure

Registration number: 07378936

Prepared for the registrar

Millennium Veterinary Practice Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 September 2024

 

Millennium Veterinary Practice Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 10

 

Millennium Veterinary Practice Limited

Company Information

Directors

S Van Poucke

L Nice

Registered office

1 Millennium Way
Braintree
Essex
CM7 3GX

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Millennium Veterinary Practice Limited

(Registration number: 07378936)
Balance Sheet as at 30 September 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

4

324,000

378,000

Tangible assets

5

230,717

236,303

 

554,717

614,303

Current assets

 

Stocks

88,102

91,039

Debtors

6

134,262

89,196

Cash at bank and in hand

 

415,899

643,968

 

638,263

824,203

Creditors: Amounts falling due within one year

7

(777,454)

(486,787)

Net current (liabilities)/assets

 

(139,191)

337,416

Total assets less current liabilities

 

415,526

951,719

Creditors: Amounts falling due after more than one year

9

(224,599)

(45,119)

Deferred tax liabilities

8

(47,432)

(48,455)

Net assets

 

143,495

858,145

Capital and reserves

 

Called up share capital

10

478

697

Capital redemption reserve

522

303

Retained earnings

142,495

857,145

Shareholders' funds

 

143,495

858,145

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

Millennium Veterinary Practice Limited

(Registration number: 07378936)
Balance Sheet as at 30 September 2024

Approved and authorised by the Board on 1 February 2025 and signed on its behalf by:
 


S Van Poucke
Director


L Nice
Director

 

Millennium Veterinary Practice Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
1 Millennium Way
Braintree
Essex
CM7 3GX

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's current forecasts and projections, together with the facilities available to the company, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

 

Millennium Veterinary Practice Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

No key sources of uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and equipment

15% of written down value

Fixtures and fittings

10% of written down value

Motor vehicles

25% of written down value

Office equipment

33.3% of cost

Goodwill

Goodwill is amortised over its useful life, estimated by the directors to be 20 years.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

 

Millennium Veterinary Practice Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Millennium Veterinary Practice Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.


Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.


Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

 

Millennium Veterinary Practice Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

 

5

Tangible assets

Fixtures and fittings
 £

Motor vehicles
 £

Plant and machinery
 £

Office equipment
 £

Total
£

Cost

At 1 October 2023

181,994

60,794

273,155

19,796

535,739

Additions

3,379

-

15,593

17,583

36,555

At 30 September 2024

185,373

60,794

288,748

37,379

572,294

Depreciation

At 1 October 2023

89,367

24,694

168,058

17,317

299,436

Charge for the year

9,132

9,025

17,213

6,771

42,141

At 30 September 2024

98,499

33,719

185,271

24,088

341,577

Carrying amount

At 30 September 2024

86,874

27,075

103,477

13,291

230,717

At 30 September 2023

92,627

36,100

105,097

2,479

236,303

 

Millennium Veterinary Practice Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

 

6

Debtors

2024
£

2023
£

Trade debtors

45,457

31,841

Prepayments

9,180

22,097

Other debtors

79,625

35,258

134,262

89,196

 

7

Creditors

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

9

254,375

67,779

Trade creditors

 

74,697

83,480

Taxation and social security

 

387,440

272,345

Accruals and deferred income

 

19,397

18,637

Other creditors

 

41,545

44,546

 

777,454

486,787

 

8

Deferred tax

Deferred tax assets and liabilities

2024

Liability
£

Difference between amortisation, accumulated depreciation and capital allowances.

47,432

47,432

2023

Liability
£

Difference between amortisation, accumulated depreciation and capital allowances.

48,455

48,455

 

9

Loans and borrowings

Current loans and borrowings

2024
£

2023
£

Bank borrowings

70,288

66,843

Other borrowings

184,087

936

254,375

67,779

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

224,599

45,119

 

Millennium Veterinary Practice Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

 

10

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary A shares of £0.00 each

-

-

166,460

166.46

Ordinary B shares of £0.00 each

-

-

-

-

Ordinary C shares of £0.00 each

238,798

238.80

232,222

232.22

Ordinary D shares of £0.00 each

-

-

65,762

65.76

Ordinary F shares of £0.00 each

238,798

238.80

232,222

232.22

Ordinary H shares of £0.00 (2023 - £0) each

1

-

-

-

Ordinary G shares of £0.00 (2023 - £0) each

1

-

1

-

Ordinary I shares of £0.00 (2023 - £0) each

1

-

-

-

 

477,599

478

696,667

697

During the year the company purchased 166,459 Ordinary A shares from Robin Creighton (retired director). The shares were purchased at a premium of £715,937.

During the year the company purchased 52,609 Ordinary D shares from Dorothy Green. The shares were purchased at a premium of £226,270.

On 31 July 2024, 1 Ordinary A share was re-designated as 1 Ordinary H share. 13,153 Ordinary D shares were re-designated as 6,576 Ordinary C shares, 6,576 Ordinary F shares and 1 Ordinary I share.

The different share classes referred to above carry separate rights to dividends.

 

11

Related party transactions

Key management personnel

Key management personnel are considered to be the directors of the company.

Transactions with directors

2024

At 1 October 2023
£

Advances to director
£

At 30 September 2024
£

L Nice

Amount due to/(from) director

312

(41,225)

(40,913)